To explore whether targeting ZNF416 could prevent further progression of established fibrosis in vivo, we used ZNF416 siRNA-loaded liposomes to treat silica- and BLM-induced mouse pulmonary fibrosis models ( Fig. 7A and Additional file 1: Fig. S7A). The gene discussed is ZNF416; the disease is pulmonary fibrosis.